Cleveland Biolabs


Thursday Morning Insights: Merrimack Pharmaceuticals Inc (MACK), Conatus Pharmaceuticals Inc (CNAT), Cleveland Biolabs, Inc. (BCLI)

Merrimack Pharmaceuticals IncĀ (NASDAQ:MACK) shares jumped over 9% in pre market trading to $12.98 after its New Drug Application for MM-398 was accepted for …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts